B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs include rituximab.

---

B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs include rituximab, ibritumab tiuxetan, ofatumumab, obinutuzumab and tositumomab. 3D rendering based on protein data bank entry 1s8b. Atoms shown as color-coded spheres. Per chain coloring.

---

Size: 4096px × 4096px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, -lymphocyte, 20, 3d, acid, amino, antibody, antigen, arthritis, atoms, background, cd, cd20, cluster, differentiation, disease, health, histology, ibritumab, illustration, immunohistochemistry, leukemia, lupus, lymphocyte, lymphoma, model, molecular, molecule, ms4a1, multiple, obinutuzumab, pdb_1s8b, peptide, polymer, polypeptide, protein, rendering, rheumatoid, rituximab, science, scientific, sclerosis, structure, surface, tiuxetan, veltuzumab, white